We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Invitrogen Introduces Dynachip™ HLA Antibody Analysis System

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Invitrogen Introduces Dynachip™ HLA Antibody Analysis System"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Invitrogen Corporation has introduced its DynaChip™ HLA Antibody Analysis system.

DynaChip™ technology will utilize an automated microarray platform to detect antibody reaction to specific HLA antigens. 

The DynaChip™ technology is developed as a result of collaboration between German array developer Clondiag, a unit of Inverness Medical Innovations, Inc., and Invitrogen.

The product is designed to perform upto 96 tests at the same time in a fully automated manner, with each test including an array of proteins.

The system includes software that can allow for rapid analysis of results. The DynaChip™ system is currently available in Europe under a CE mark and is available for ‘research use only’ in the United States.

It is in the process of obtaining FDA 510K clearance in the United States.